A quiet but seismic shift is reshaping personal injury litigation in 2026. In February 2026, New York’s governor signed the Consumer Litigation Funding Act, a comprehensive piece of legislation regulating consumer litigation funding. Senators Chuck Grassley, Thom Tillis, John Kennedy, and John Cornyn introduced the Litigation Funding Transparency Act of 2026, which would require disclosure of third-party litigation funding, as well as the underlying funding agreements, in federal class actions and federal multi-district litigation proceedings. For the first time, a New York appellate court allowed defendants in a personal injury case to discover third-party litigation funding, highlighting a shift toward greater transparency and fraud prevention in lawsuits. For injured plaintiffs, defense teams, and insurance carriers alike, litigation funding disclosure 2026 personal injury law is no longer a niche compliance issue. It is the defining battleground of modern tort reform.
What Is Litigation Funding and Why Does It Matter in 2026?
Litigation funding — also called third-party litigation funding (TPLF) — involves outside investors providing capital to plaintiffs or law firms to cover legal costs and living expenses during a case. In exchange, the funder receives a portion of any eventual recovery. What began as a niche tool for resource-strapped plaintiffs has grown into a multibillion-dollar industry that some analysts now describe as a powerful force driving settlement inflation across the entire personal injury landscape.
Consumer-level funding arrangements typically involve amounts under $10,000, with funds typically used for personal living expenses such as rent, utilities, groceries, or medical bills. Commercial funding — the kind that flows into mass tort litigation, class actions, and high-value personal injury cases — routinely involves millions of dollars per case. That distinction matters enormously, because it is the commercial tier that has drawn legislative and judicial scrutiny in 2026.
The litigation funding investment market was valued at USD 20.64 billion in 2025 and is projected to reach USD 51.09 billion by the end of 2036, rising at a CAGR of 8.08%. Recent analysis by Ernst & Young (EY) estimates that TPLF could impose up to $50 billion in additional costs on the American insurance industry over the next five years, which translates roughly to a 4%–5.2% drag on annual loss ratios. When outside investors with no stake in a claimant’s wellbeing stand to profit from higher verdicts, critics argue the incentive structure systematically pushes settlements — and jury awards — upward. According to Swiss Re’s Social Inflation Index, social inflation increased liability claims in the US by 57% in the past decade and reached an annual peak of 7% in 2023, with litigation funding identified as a significant structural contributor to that inflation. That 57% figure has become the centerpiece of insurance industry arguments for transparency mandates in 2026.
New York’s 2026 Litigation Funding Law: What Changed
In February 2026, New York’s governor signed the Consumer Litigation Funding Act, a comprehensive piece of legislation regulating consumer litigation funding. The Act takes effect on June 17, 2026, with most substantive provisions becoming effective on that date, including contract requirements, disclosure obligations, attorney acknowledgment requirements, consumer protections, rescission rights, charge limitations, and restrictions on funding practices. The law addresses litigation funding disclosure 2026 personal injury requirements on multiple fronts simultaneously, creating new obligations for funders, new rights for defendants, and new protections for plaintiffs. Separately, on May 27, 2026, Governor Kathy Hochul signed New York’s 2026 state budget into law, a $268.1 billion budget that includes significant tort reform provisions for New York State motor vehicle litigation.
Key Provisions of the New York Consumer Litigation Funding Act
- 25% cap on funder compensation: The law limits the maximum recovery of the financing company to 25% of the gross recovery of the claim, directly limiting the financial incentive to prolong litigation for larger verdicts.
- 10-day cancellation right: The new law requires that contracts be written in plain, clear language, and gives plaintiffs a rescission period of 10 days.
- Bar on strategy steering and referral fees: Under the new law, funding companies are forbidden from referring clients to specific lawyers or medical providers, directly responding to documented conflicts of interest between funders, law firms, and medical providers.
- Attorney acknowledgment requirement: The statute requires attorneys who represent the consumer seeking funding to execute an Acknowledgment of Counsel (AOC) for a funding contract to be valid.
- Mandatory funder registration: All consumer litigation funding companies must register with the state, submit to character and fitness evaluations, and post a bond — creating a public registry of authorized funders that could help drive the most predatory lenders out of New York.
- Payment schedule transparency: Repayment must be a predetermined amount based on time intervals from funding through settlement — not a percentage of the recovery — and the funding agreement must include a payment schedule listing the funded amount and charges due at the completion of each 180-day interval, up to the maximum amount owed.
- No prohibition on misleading advertising: The law also aims to prohibit misleading advertising to prospective plaintiffs, protecting the public at large.
Beyond the Consumer Litigation Funding Act, New York enacted sweeping auto insurance and tort reforms in its FY2027 budget, including a 51% modified comparative fault standard for motor vehicle collisions, sequenced trials, limits on pain-and-suffering awards for drivers who are uninsured or driving while intoxicated or impaired, and new penalties for staged accidents. For the first time, a New York appellate court also allowed defendants in a personal injury case to discover third-party litigation funding, highlighting a shift toward greater transparency and fraud prevention in lawsuits.
The Federal Bill: National Disclosure Standards for Class Actions and Mass Torts
Senators Chuck Grassley (R-IA), Thom Tillis (R-NC), John Kennedy (R-LA), and John Cornyn (R-TX) introduced the Litigation Funding Transparency Act of 2026, which would require disclosure of third-party litigation funding, as well as the underlying funding agreements, in federal class actions and federal multi-district litigation proceedings (MDLs). The legislation, formally designated S. 3826, has been referred to the Senate Judiciary Committee and represents the most serious congressional push for uniform national disclosure standards to date.
What the Federal Bill Requires
- Mandatory identity disclosure: The legislation requires parties to disclose the identity of any third-party funder involved in a covered civil action.
- Scope — class actions, MDLs, and large coordinated proceedings: The bill applies to class actions, multidistrict litigation, and large coordinated federal proceedings involving one hundred or more cases.
- Bar on funder control: The bill would also prohibit funders in class actions and MDLs from being able to control decision-making or the overall activities in the litigation.
- Restricted access to discovery materials: Third-party funders are restricted from accessing discovery materials that are protected under court orders, ensuring confidentiality during the legal process.
- Foreign adversary focus: The bill reflects rising congressional concern about the influence of foreign sovereign entities, foreign individuals, and foreign-controlled commercial enterprises in U.S. litigation.
- Contempt for violations: The act prohibits third-party funders from exerting influence over litigation decisions, strategies, or settlements, and violating this provision can lead to contempt of court.
The U.S. Chamber of Commerce, the American Property Casualty Insurance Association (APCIA), the National Insurance Crime Bureau (NICB), and the High Tech Inventors Alliance all support the Litigation Funding Transparency Act. The bill is currently pending review in the Senate Committee on the Judiciary. Florida has also moved aggressively at the state level — Florida’s disclosure requirements apply to legal proceedings pending on or commenced on or after July 1, 2026, with the bill effective as of that date.
How Disclosure Requirements Are Reshaping Insurance Defense Strategy
Litigation financing has moved from a niche funding mechanism to a powerful force shaping claims severity, settlement dynamics, and, ultimately, insurance costs. According to Swiss Re’s analysis, liability claim severity has increased by 57% over the past decade, driven by large verdicts and awards exceeding $100 million. Katie Evans, executive vice president and chief legal officer at CSAA Insurance Group, believes 2026 could mark a turning point in how the industry responds: “In 2026, carriers will push back against the distortive effects of litigation financing by coupling data-driven defense analytics with policy-level transparency reforms.”
Insurance Industry Response in 2026
The insurance industry’s reaction to the 2026 wave of disclosure legislation has been swift and coordinated. Carriers are pursuing coordinated efforts including model law updates, disclosure mandates, and early-resolution protocols to curb speculative suits. On the pricing side, rates rose 2.6% for general liability and 5.8% for auto liability on average, while median lead umbrella price per million rose 8.0% and median excess casualty price per million rose 7.6%.
Several U.S. states, including Georgia, Kansas, Indiana, Louisiana, Montana, West Virginia, and Wisconsin, have passed laws requiring greater disclosure of funders’ identities and financial interests, with others considering similar measures. Georgia’s approach is particularly notable: effective January 1, 2026, third-party litigation funders must register with the Georgia Department of Banking and Finance and may be held jointly and severally liable for frivolous litigation.
Critics have raised concerns that funding agreements imposed excessive fees and created incentives to prolong litigation or inflate settlement demands — factors that have contributed to rising claim severity and defense costs, with downstream effects on insurance premiums. Defense counsel have responded by demanding funding disclosures early in discovery, using identified funder interests to challenge settlement demands, and pushing for sequenced trial structures that resolve liability before damages. Large jury verdicts, prolonged litigation timelines, and third-party litigation funding continue to inflate reserves and extend settlement cycles, requiring more rigorous documentation, earlier risk assessment, and tighter coordination between claims and legal teams.
Litigation Funding Disclosure 2026: Key Statistics at a Glance
- $20.64 billion: The litigation funding investment market size was valued at USD 20.64 billion in 2025, with projections toward $51 billion by 2036.
- $50 billion: Ernst & Young’s analysis estimates that TPLF could impose up to $50 billion in additional costs on the American insurance industry over the next five years.
- 57%: Social inflation increased U.S. liability claims by 57% over the past decade, primarily due to a rising number of large court verdicts.
- 135 nuclear verdicts in 2024: Nuclear verdicts (over $10 million) increased 52% in 2024, with 135 total nuclear verdicts and a median of $51 million.
- 20%–30% increase in plaintiff win probability: Research found statistically significant relative increases in plaintiff win probability of approximately 20%–30% from 2009 to 2024, alongside a statistically significant relative decline in settlement probability of more than 10% over the same period.
- Verdict severity up more than 100%: Even after controlling for explanatory variables, verdict awards show a sharp rise after 2020, increasing by more than 100% from 2020 to 2024.
- 8+ states, 1 major federal bill: At least seven states wrote new funding rules into law in 2025, Georgia among them, and a federal bill introduced in February 2026 by a bipartisan group of senators would force disclosure of funders, including foreign ones, in federal class actions and mass torts.
- $182 million: A global settlement of $182 million was reached in 2026 in the Metro-North Valhalla train crash litigation, resolving claims for families of passengers who were killed in the 2015 collision — one of the largest commuter rail accident recoveries reported in New York history.
What Litigation Funding Disclosure Means for Injured Plaintiffs in 2026
For injured plaintiffs, the 2026 wave of disclosure legislation is a double-edged development. On one hand, the new rules provide genuine consumer protections that were largely absent before. On the other hand, they introduce new friction into the funding process that could reduce access to capital for some injured people waiting years for their cases to resolve.
While intended to protect plaintiffs, the law may restrict access to vital funds, potentially forcing injured victims to accept low offers. The legislation imposes extensive registration and reporting burdens on funding companies, raising concerns about increased costs and reduced availability of pre-settlement funds. Litigation funding in the personal injury field has for many years been a lifeline for seriously injured plaintiffs who suddenly find themselves unable to continue to support themselves and their families as they litigate with the parties responsible for their disabilities.
The plaintiff-side concerns are most acute in commercial funding. TPLF can increase claim severity by enabling holdout strategies that bypass early settlement, and it inflates the proportion of claims reaching trial, shifting the loss distribution toward the extreme tail. When that leverage is constrained by mandatory disclosure, plaintiffs in high-value cases may find that funders are less willing to commit capital on terms that satisfy the new statutory requirements. Critics argue it would be a major blow to injured plaintiffs because many cases would not be fundable under the most restrictive versions of the Act.
For most personal injury plaintiffs, however — those with consumer-level funding needs under $10,000 — the new framework offers meaningful protections: capped fees, plain-language contracts, a 10-day cancellation window, and a ban on funder referrals to specific attorneys or medical providers. New York’s enactment of litigation funding reform marks a significant shift in the state’s legal and insurance landscape. While not a complete solution, the new law introduces meaningful consumer safeguards and could help curb practices that have contributed to rising litigation costs.
The Road Ahead: Will 2026 Mark the Transparency Tipping Point?
2026 is shaping up to be a pivotal year for TPLF, with landmark legislative proposals, judicial decisions, and regulatory developments across the U.S., UK, and EU. The convergence of New York’s Consumer Litigation Funding Act, the sweeping FY2027 auto tort reforms, the appellate court’s discovery ruling, the federal Litigation Funding Transparency Act of 2026, Florida’s new disclosure law, and Georgia’s funder registration mandate represents the most coordinated multi-front push for TPLF transparency in U.S. history.
Whether that push constitutes a true tipping point depends on two unknowns: whether the Grassley bill advances out of the Senate Judiciary Committee, and whether the states that have passed disclosure laws will see measurable reductions in claim severity within a meaningful timeframe. The continuing wave of reforms reflects growing national concern that TPLF can increase litigation costs, prolong claims, and allow outside investors to influence litigation strategy — as well as broader concerns about social inflation, large verdicts, and perceived abuses within the legal system.
State tort reforms targeting third-party litigation funding are gaining momentum, but social inflation and rising liability costs continue to challenge insurance buyers. In the near term, third-party litigation funding, social inflation, large verdicts and settlements, and adverse loss development will remain key considerations in liability placements. Even where reform efforts improve transparency or help rebalance the playing field, buyers should not assume they will quickly reverse the pricing, attachment-point, capacity, or coverage pressures that have reshaped the liability marketplace.
For personal injury litigants — plaintiffs and defendants alike — the practical reality of 2026 is that the rules of engagement around litigation funding are changing fast. Staying current with state-specific disclosure requirements, understanding how funder involvement affects settlement leverage, and knowing your rights under the new consumer protections are now essential elements of navigating any significant personal injury claim.
Frequently Asked Questions About Litigation Funding Disclosure in Personal Injury Cases
What is litigation funding disclosure and why does it matter in personal injury cases in 2026?
Litigation funding disclosure requires parties in a lawsuit to reveal when an outside investor is financing their case in exchange for a share of any recovery. It matters in 2026 because third-party litigation funding “operates largely in secret,” allowing funders to invest in high-dollar litigation without appearing on court dockets or being subject to meaningful oversight. Without disclosure, defense teams and insurers cannot accurately assess the true settlement incentives at play — or identify whether a foreign adversary is involved in U.S. litigation.
Does New York’s 2026 litigation funding law protect plaintiffs or hurt them?
Both. The new regulatory scheme, which took effect June 17, 2026, introduces fee caps, lender-registration requirements, standardized agreements, and transparency measures that may expedite settlement, limit unreasonable demands, and help attorneys avoid potential liability. However, the registration and compliance burden may reduce the number of funders willing to operate in New York, potentially limiting options for plaintiffs who need pre-settlement cash advances to survive financially while their cases proceed.
What does the 2026 federal litigation funding disclosure bill require?
If passed, the Litigation Funding Transparency Act of 2026 would require disclosure of outside investors in federal class actions and multi-district litigation, restrict funders from controlling legal strategies, and bar their access to confidential discovery materials. It does not apply to individual personal injury cases in state court — only to federal class actions, MDLs, and large coordinated proceedings of 100 or more cases.
How does litigation funding contribute to claim severity inflation in personal injury cases?
Social inflation is a phenomenon where insured liability claims increase faster than can be explained by economic factors. Outsized awards and settlements in tort disputes are driven by various socioeconomic, legislative, and litigation trends, such as legal system abuse, third-party litigation funding, and escalating compensation verdicts. Funders often invest in sophisticated legal strategies, financing mock trials, shadow juries, and expert witnesses that a plaintiff could not otherwise afford. This preparation increases the likelihood of high jury awards. When juries hand down massive verdicts, it resets the bar for what is considered a “normal” settlement in future cases.
Can I still use litigation funding for my personal injury case in 2026?
Yes. Repayment is typically contingent on a successful recovery, and there is generally no repayment obligation if the plaintiff does not prevail. However, the terms under which you can obtain funding have changed in many states. In New York, you must receive a plain-language contract, have 10 days to cancel, and your attorney must sign an acknowledgment. Funder compensation is now capped at 25% of your gross recovery. In Florida and Georgia, your funding arrangement may now be subject to disclosure in discovery. Shop carefully, read your contract, and consult your attorney before signing any funding agreement in 2026.
Thomas B. Harrison is a personal injury legal consultant with extensive experience connecting injury victims with qualified attorneys across the United States. He specializes in helping people understand when they need legal representation and how to find the right personal injury attorney for their specific situation. Thomas is not an attorney and the information he provides is for educational purposes only.